AC Immune Reports Top Line Results from TAURIEL Phase 2 Trial Evaluating Semorinemab in Early Alzheimer’s Disease
Clinical Stage PipelineClinical Stage Pipeline. Readout in 2020.Clinical Stage Pipeline. Readout in 2020.Early-stage PipelineEarly-stage Pipeline. Key milestone in 2020.Early-stage Pipeline. Key milestone in 2020.Genentech disclosed...